Որոնման արդյունքները - Saša Masleša-Galić
- Ցուցադրվում են 1 - 5 արդյունքները 5
-
1
Recombinant bacillus Calmette–Guérin (BCG) vaccines expressing the<i>Mycobacterium tuberculosis</i>30-kDa major secretory protein induce greater protective immunity against tubercu... Marcus A. Horwitz, Günter Harth, Barbara Jane Dillon, Saša Masleša-Galić
Հրապարակվել է 2000Artigo -
2
All four <i>Mycobacterium tuberculosis gln</i>A genes encode glutamine synthetase activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasis Günter Harth, Saša Masleša‐Galić, Michael V. Tullius, Marcus A. Horwitz
Հրապարակվել է 2005Artigo -
3
A Replication-Limited Recombinant <i>Mycobacterium bovis</i> BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacio... Michael V. Tullius, Günter Harth, Saša Masleša-Galić, Barbara Jane Dillon, Marcus A. Horwitz
Հրապարակվել է 2008Artigo -
4
Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters Qingmei Jia, Helle Bielefeldt‐Ohmann, Rachel M. Maison, Saša Masleša-Galić, Sarah K. Cooper, Richard A. Bowen, Marcus A. Horwitz
Հրապարակվել է 2021Artigo -
5
Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time Bai‐Yu Lee, Daniel L. Clemens, Aleidy Silva, Barbara Jane Dillon, Saša Masleša-Galić, Susana Nava, Xianting Ding, Chih‐Ming Ho, Marcus A. Horwitz
Հրապարակվել է 2017Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Biology
Medicine
Pathology
Biochemistry
Gene
Microbiology
Mycobacterium tuberculosis
Tuberculosis
Immunology
Virology
Attenuated vaccine
BCG vaccine
Molecular biology
Mycobacterium bovis
Recombinant DNA
Tuberculosis vaccines
Vaccination
Virulence
Amino acid
Bacilli
Bacteria
Bedaquiline
Biotechnology
Coronavirus disease 2019 (COVID-19)
Disease
Drug
Drug resistance
ESAT-6
Enzyme
Genetics